Sep 13, 2022 | Blog, Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Dentsply Sirona Inc. (“Dentsply”) (NASDAQ: XRAY) breached their fiduciary duties to Dentsply and its shareholders.
The investigation concerns whether members of the Dentsply Board of Directors (the “Board”) made, or caused Dentsply to make, false and/or misleading statements, as well as failed to disclose material adverse facts, about Dentsply’s business, operations, prospects, and financial health.
Further, the investigation is focusing on whether the Board failed to disclose material information, including whether: (i) Dentsply improperly recognized revenue tied to certain dealer incentives or rebate programs to allow its former CEO and CFO to meet certain incentive-based compensation targets; and (ii) as a result, whether statements about Dentsply’s business, operations, and prospects lacked a reasonable basis.
On April 19, 2022, Dentsply announced the sudden termination of its CEO. On this news, the price of Dentsply shares dropped 13%.
On May 10, 2022, Dentsply announced that the Audit Committee of the Board had commenced an internal investigation regarding Dentsply’s “use of incentives to sell products to distributors” and “whether those incentives were properly accounted for.” As a result, Dentsply was unable to file its quarterly report with the SEC. On this news, the price of Dentsply shares dropped 7%.
DENTSPLY SHAREHOLDERS ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS ABOUT THEIR DENTSPLY STOCK HOLDINGS.
Aug 31, 2022 | Blog, Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Pzena Investment Management, Inc. (“Pzena”) (NYSE: PZN) breached their fiduciary duties to Pzena’s shareholders.
The investigation concerns whether Pzena’s board of directors or executive officers breached their fiduciary duties of loyalty and whether Pzena’s shareholders are receiving a fair price for their stock in connection with the proposed sale of Pzena to Richard Pzena, Pzena’s founder and Chief Executive Officer.
INVESTORS OF PZENA STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS ABOUT THEIR PZENA STOCK HOLDINGS.
IF YOU ARE A PZENA SHAREHOLDER, YOU MAY HAVE LEGAL CLAIMS AGAINST PZENA’S DIRECTORS AND OFFICERS. IF YOU WISH TO DISCUSS THIS INVESTIGATION, OR HAVE QUESTIONS ABOUT THIS NOTICE OR YOUR LEGAL RIGHTS, PLEASE CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.
Aug 31, 2022 | Blog, Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Abbott Laboratories (“Abbott”) (NYSE: ABT) breached their fiduciary duties to Abbott and its shareholders.
The investigation concerns whether members of Abbott’s board of directors or senior management failed to manage Abbott in an acceptable manner, in breach of their fiduciary duties to Abbott, and whether Abbott and its shareholders suffered damages as a result.
INVESTORS OF ABBOTT STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS ABOUT THEIR ABBOTT STOCK HOLDINGS.
On May 16, 2022, the U.S. filed a lawsuit and proposed consent decree against Abbott claiming that Abbott manufactured powdered infant formula under conditions and using practices that failed to comply with regulations designed to ensure the quality and safety of infant formula.
IF YOU ARE AN ABBOTT SHAREHOLDER, YOU MAY HAVE LEGAL CLAIMS AGAINST ABBOTT’S DIRECTORS AND OFFICERS. IF YOU WISH TO DISCUSS THIS INVESTIGATION, OR HAVE QUESTIONS ABOUT THIS NOTICE OR YOUR LEGAL RIGHTS, PLEASE CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.
Aug 29, 2022 | Blog, Shareholder Investigations
Azure Power Investors With Losses Greater Than $50,000 Are Encouraged to Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating claims on behalf of investors of Azure Power Global Limited (“Azure Power Global” or the “Company”) (NYSE: AZRE) to determine whether the Company violated securities laws or engaged in other unlawful business practices.
INVESTORS OF AZURE POWER GLOBAL STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS ABOUT THEIR AZRE STOCK HOLDINGS.
On August 29, 2022, the Company reported that it “. . . received a whistleblower complaint in May 2022 alleging potential procedural irregularities and misconduct by certain employees at a plant belonging to one of its subsidiaries.”
The Company also reported that “[a]s part of the Company’s review of these allegations, it discovered deviations from safety and quality norms, and it has implemented mechanisms to remediate them and in so doing strengthen safety and quality protocols. Azure’s Audit Committee, with the assistance of legal counsel and forensic accounting support, also identified evidence of manipulation of project data and information by certain employees. The Company is implementing immediate remedial measures, and Azure is initiating disclosure of the findings to the appropriate authorities.”
Further, the Company’s recently appointed CEO resigned unexpectedly after joining Azure Power Global two months earlier in July 2022.
Azure Power Global’s stock price was down more than 40% during intraday trading on August 29, 2022.
AZURE POWER GLOBAL INVESTORS WITH LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO CONTACT KEHOE LAW FIRM, P.C, MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.
Aug 11, 2022 | Blog, Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether certain directors of Zendesk, Inc. (“Zendesk”) (NYSE: ZEN) breached their fiduciary duties to Zendesk’s shareholders.
INVESTORS OF ZENDESK STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS ABOUT THEIR ZENDESK STOCK HOLDINGS.
The investigation concerns whether Zendesk’s board of directors or executive officers breached their fiduciary duties of loyalty and whether Zendesk’s shareholders are receiving a fair price for their stock in connection with the proposed sale of Zendesk to a private investor group led by Hellman & Friedman and Permira.
If you are a Zendesk shareholder, you may have legal claims against Zendesk’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.
Jul 20, 2022 | Blog, Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether the directors of Covetrus, Inc. (“Covetrus”) (NASDAQ: CVET) breached their fiduciary duties to its shareholders in approving a buyout with funds affiliated with Clayton, Dubilier & Rice (“CD&R”) and TPG Capital (“TPG”) for inadequate consideration.
INVESTORS OF COVETRUS STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS ABOUT THEIR COVETRUS STOCK HOLDINGS.
On May 25, 2022, Covetrus announced it had reached an agreement to be bought out by funds affiliated with CD&R and TPG for $21.00 per share, in an all-cash transaction valued at approximately $4 billion.
The investigation concerns whether Covetrus’s board of directors failed to maximize the value of Covetrus for the benefit of Covetrus’s shareholders in connection with its announced buyout by funds affiliated with CD&R and TPG, in breach of their fiduciary duties to Covetrus’s shareholders, and whether Covetrus’s shareholders suffered damages as a result.
COVETRUS SHAREHOLDERS ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.
